Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/11/2025 ,inter alia, to consider and approve Reschedule of Board Meeting supposed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has informed BSE that its Board of Directors meeting, originally planned for November 14, 2024, has been rescheduled to November 15, 2025 due to unavoidable reasons. The meeting will consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025. The company had earlier made a corporate announcement on November 07, 2025 regarding the original meeting date. The intimation has been signed by Managing Director Umang Alkesh Gosalia.
This is a routine administrative disclosure and does not directly impact shareholders or the stock price. Investors should watch for the actual Q2/H1 FY26 results to be announced at the rescheduled meeting on November 15, 2025.